Biofrontera AG
DelistedCIK 1712641fmd_1ARPKC63EV6XMT8SF1XDHCZBGJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2020, 9 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|---|
| Total revenues | 4 | 6 | 12 | 21 | 31 | 30 |
| Cost of revenue | 1 | 2 | 2 | 4 | 5 | 4 |
| Gross profit | 3 | 4 | 10 | 17 | 26 | 27 |
| Research and development | (6) | 5 | 4 | 4 | 5 | 5 |
| Selling, general and administrative | 0 | 0 | 0 | 0 | 0 | 1 |
| Operating income | (10) | (12) | (14) | (18) | (23) | (8) |
| Interest expense | (0) | (1) | (1) | 2 | 2 | 3 |
| Income before taxes | (11) | (11) | (16) | (19) | (5) | (13) |
| Income tax expense | – | – | – | (10) | 3 | 0 |
| Net income from continuing operations | – | – | – | (9) | (7) | (13) |
| Net income | (11) | (11) | (15) | (10) | (8) | (11) |